PI3K酶的ATP竞争性抑制剂通过控制膜结合来表现出异形选择性双重作用
Grace Q Gong1,2, Glenn R Masson3, Woo-Jeong Lee1
1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand.
The Biochemical journal
|November 1, 2024
概括
这项研究表明,ATP位点抑制剂阻断增长因子激活的PI3Kα膜相互作用. 然而,瘤基因突变可以使这种相互作用对这些抑制剂不敏感,突出复杂的PI3Kα调节.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 氨基酸3-酶α (PI3Kα) 在细胞信号传递中至关重要,其失调与癌症有关.
- PIK3CA突变是常见的致癌驱动因素,导致开发针对p110α催化子单元的ATP位点抑制剂.
- 这些抑制剂对PI3Kα的膜相互作用的影响,这是其激活的关键步骤,仍然在很大程度上未被探索.
研究的目的:
- 研究ATP位点定向抑制剂对野生型 (WT) 和突变PI3Kα.的膜相互作用的影响.
- 了解这些抑制剂调节PI3Kα膜结合的机制.
- 探索PI3Kα膜相互作用的潜在基质基调.
主要方法:
- 福斯特共振能量转移 (FRET) 测试.
- 生物层干涉计 (BLI).生物层干涉计.
- 使用了特定的抑制剂,如GSK2126458和ATP基质类似物.
主要成果:
- ATP位点抑制剂,如GSK2126458,通过要求酶回归基底状态来抑制增长因子激活PI3KαWT膜相互作用.
- 在"热点"区域的致癌突变赋予了对GSK2126458介导的膜相互作用抑制的耐药性.
- 热点以外的突变对GSK2126458表现出敏感性,而ATP基质类似物增强PI3KαWT膜相互作用.
结论:
- PI3Kα膜相互作用是由ATP位点定向抑制剂调节的,但这种调节被某些致癌突变所绕过.
- 基质结合可以调节PI3Kα膜相互作用,提供一种替代的调节机制.
- PI3Kα膜协会是一种可药物注的标,受ATP位和基调节器的影响.
更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
8.5K
相关概念视频
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Enzyme Inhibition
78.0K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.0K
IP3/DAG Signaling Pathway
11.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K
